ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652538 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652538; 2) Community: the network communities that were significantly associated with the response to NSC 652538; 3) Molecule: the relationships between components within communities and NSC 652538; 4) MDR: the compounds that were significantly associated with the NSC 652538.

NSC Compound Enrichment Correlation
NSC 732825 N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide 0.0385613993886001 0.28556002
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0385613993886001 -0.083353987
NSC 756420 SB-223133 0.0385613993886001 -0.32160711
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0385613993886001 0.19511619
NSC 114382 Null 0.0414190425892865 0.40116268
NSC 116693 Null 0.0414190425892865 0.2468755
NSC 116878 Cardiac glycoside 0.0414190425892865 -0.13436312
NSC 123978 Sarveroside 0.0414190425892865 0.0080107451
NSC 134754 Null 0.0414190425892865 0.052929704
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0414190425892865 0.077381168
Total:80  Current:59    [First] [Prev] [Next] [Last]